Sanofi (SNY) Inventory (2009 - 2026)

Sanofi has disclosed Inventory across 18 years of filings, most recently posting $12.9 billion for Q2 2026.

• In Q2 2026, Inventory rose 18.8% year-over-year to $12.9 billion; the TTM figure through Jun 2026 stood at $12.9 billion (up 18.8% YoY), while the FY2025 annual figure was $11.9 billion, up 16.48% from the prior year.
• Inventory came in at $12.9 billion for Q2 2026 at Sanofi, up from $11.9 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $12.9 billion in Q2 2026 to a low of $9.1 billion in Q4 2022.
• Average Inventory over 5 years is $10.8 billion, with a median of $10.9 billion recorded in 2023.
• Year-over-year, Inventory dropped 10.39% in 2022 and climbed 18.8% in 2026.
• Over 5 years, Inventory stood at $9.1 billion in 2022, then climbed by 13.77% to $10.4 billion in 2023, then retreated by 3.1% to $10.1 billion in 2024, then increased by 17.98% to $11.9 billion in 2025, then increased by 8.78% to $12.9 billion in 2026.
• Per Business Quant data, the three most recent Inventory figures were $12.9 billion in Q2 2026, $11.9 billion in Q4 2025, and $10.9 billion in Q2 2025.